Concepedia

E. Sathyajith Kumarasinghe

ES

Statistics

Publications

9

Citations

1.3K

H-Index

9

Active since

2000

Affiliations

Moderna Therapeutics (United States)(Current)

Bayer (Germany)

Bayer (United States)

E. Sathyajith Kumarasinghe is an author at Moderna Therapeutics (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

2000–2019

9

Publications

9

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

Staci Sabnis, E. Sathyajith Kumarasinghe, Timothy Salerno et al. · Molecular Therapy · 2018 · 753 citations · Full text

Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia

An Ding, Jessica L. Schneller, Andrea Frassetto et al. · Cell Reports · 2017 · 249 citations · Full text

, , +21

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Lei Jiang, Pedro Berraondo, Daniel Jericó et al. · Nature Medicine · 2018 · 176 citations · Full text

mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency

Jingsong Cao, An Ding, Mikel Galduroz et al. · Molecular Therapy · 2019 · 71 citations · Full text

PDE-10A inhibitors as insulin secretagogues

Louis‐David Cantin, Steven Magnuson, David Gunn et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 35 citations · Full text

, , +6

1–5 of 9